Beacon NewsFlashes – August 20, 2010
New Clinical Trial Recruits HIV-Discordant Couples For An Artificial Insemination Study – A new clinical trial at the Boston Medical Center is currently recruiting participants. The study will test the efficacy and safety of intrauterine insemination, a type of artificial insemination, in HIV-discordant couples (couples in which only one person is HIV positive). To be eligible, men must be HIV positive and on stable HAART with an undetectable viral load (amount of virus in the blood) and women must be HIV negative. Women will be tested for HIV status during and after pregnancy, and their babies will be tested at the age of 3 months. Researchers intend to enroll 50 participants in the pilot study. For more information, please visit the United States Clinical Trials registry.
Website Launched For 2010 National Latino AIDS Awareness Day – A new website has been launched for the 2010 National Latino AIDS Awareness Day (NLAAD). The website contains information on community events, HIV testing, and care for Latino/Hispanic-Americans. Resources are available in both Spanish and English. NLAAD will occur this year on October 15. For more information, please see the NLAAD website.
Black AIDS Institute And Merck Create New Black HIV/AIDS Advocacy Network – The Black AIDS Institute and the pharmaceutical company Merck have announced the establishment of the Black Treatment Advocates Network (BTAN). The goals of BTAN include improving HIV care and treatment for the African-American community, strengthening leadership and advocacy, and educating African-American communities about HIV and AIDS. The Network will sponsor regional training for advocates and will have an educational website. BTAN’s first action will be to set up pilot advocacy communities in Jackson, MS; Philadelphia; and Houston. For more information, please see the Black AIDS Institute and Merck websites.